How much does Upadacitinib cost?

Upadacitinib (Upadacitinib) is indicated for the treatment of adults with moderately to severely active rheumatoid arthritis who have an inadequate response to or intolerance to methotrexate; Adults with active psoriatic arthritis who should be inadequate or intolerant; adults and adolescents 12 years and older with refractory moderate to severe atopic dermatitis that is not adequately controlled with systemic therapy or whose use is not recommended;

Upadatinib is also indicated for the treatment of adults with active ankylosing spondylitis who have had an inadequate response to biologicalDMARDs or for whom these therapies are not recommended; for patients with active nonradiographic axial spondyloarthritis (nr-axSp) who have objective signs of inflammation A) Adults who have had an inadequate response to biologic DMARDs or whose use of these therapies is not recommended; and adults with moderately to severely active ulcerative colitis who have previously demonstrated treatment failure, that is, an inadequate response, loss of response, or intolerance to at least one of conventional and/or biologic therapies.

The original drug Upatinib has been launched in China, and has subsequently entered the scope of Class B medical insurance. Only eligible patients can be reimbursed. Specifications The price of each box of 15mg*28 tablets may be around RMB 3,000. The European version of the original drug sold overseas is priced at more than 20,000 yuan for 15mg*30 tablets (the price may fluctuate due to exchange rates), which is expensive. Cheaper upadatinib generic drugs are also sold overseas, and their pharmaceutical ingredients are basically the same as those of the original drugs sold domestically and abroad. For example, the price of 15mg*30 tablets produced by Bangladesh pharmaceutical factory is around 900 yuan (the price may fluctuate due to the exchange rate).